Pages that link to "Q30663292"

The following pages link to Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization (Q30663292):

Displaying 40 items.

• MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells (Q21135545) (← links)
• Mouse aortic ring assay: A new approach of the molecular genetics of angiogenesis (Q24797401) (← links)
• Pathways for aberrant angiogenesis in pancreatic cancer (Q24800215) (← links)
• Transient reduction of placental angiogenesis in PAI-1-deficient mice (Q28510418) (← links)
• Matrix metalloproteinase-9 contributes to choroidal neovascularization (Q30860298) (← links)
• Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy (Q31065469) (← links)
• Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization (Q31081886) (← links)
• Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice (Q33290573) (← links)
• Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. (Q33295022) (← links)
• Does plasminogen activator inhibitor-1 drive lymphangiogenesis? (Q33543002) (← links)
• Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization (Q33654315) (← links)
• Pleiotropic functions of plasminogen activator inhibitor-1. (Q33984228) (← links)
• uPAR: a versatile signalling orchestrator (Q34162183) (← links)
• Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration (Q34425420) (← links)
• The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment (Q34584787) (← links)
• Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat model (Q34652557) (← links)
• Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner. (Q34725029) (← links)
• Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor. (Q34887726) (← links)
• Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. (Q35020040) (← links)
• Objective area measurement technique for choroidal neovascularization from fluorescein angiography (Q35062279) (← links)
• Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies (Q35126780) (← links)
• Ocular neovascularization: a valuable model system (Q35551128) (← links)
• Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition (Q35566836) (← links)
• Manipulating angiogenesis in medicine (Q35743851) (← links)
• Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. (Q35791725) (← links)
• Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients (Q36647843) (← links)
• MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy (Q36802746) (← links)
• Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy (Q36935551) (← links)
• Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes (Q37407293) (← links)
• Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes (Q37704701) (← links)
• The Myofibroblast Is the Predominant Plasminogen Activator Inhibitor-1-Expressing Cell Type in Human Breast Carcinomas (Q41826247) (← links)
• Balancing AhR-Dependent Pro-Oxidant and Nrf2-Responsive Anti-Oxidant Pathways in Age-Related Retinopathy: Is SERPINE1 Expression a Therapeutic Target in Disease Onset and Progression? (Q41842578) (← links)
• Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1. (Q41999157) (← links)
• Plasminogen activator inhibitor-1 modulates adipocyte differentiation. (Q42483651) (← links)
• The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on PAI-1 gene expression and adipocyte differentiation (Q42818891) (← links)
• Protonation state of a single histidine residue contributes significantly to the kinetics of the reaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator (Q44807445) (← links)
• Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity. (Q45885254) (← links)
• Bone marrow plasminogen activator inhibitor-1 influences the development of obesity (Q51491433) (← links)
• Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer (Q57581296) (← links)
• Plasminogen activator inhibitor-1: the double-edged sword in apoptosis (Q83162820) (← links)